Eosinophilic Granulomatosis with Polyangiitis: Understanding This Rare Autoimmune Disease
As a rheumatologist, I often see patients who have spent years managing what they thought were unrelated health issues, such as asthma, sinus infections, allergies, nerve pain, or unexplained fatigue.
Sometimes, these symptoms are connected by a single underlying condition.
One example is Eosinophilic Granulomatosis with Polyangiitis (EGPA), formerly known as Churg-Strauss Syndrome.
EGPA is a rare autoimmune disease that causes inflammation of small and medium-sized blood vessels. It belongs to a group of conditions called ANCA-associated vasculitis, where the immune system mistakenly attacks blood vessels and causes widespread inflammation.
What makes EGPA unique is the combination of:
- Asthma
- High levels of eosinophils (a type of white blood cell)
- Blood vessel inflammation
- Organ involvement
Because EGPA can affect multiple parts of the body, symptoms often appear unrelated at first. A person may visit an asthma specialist, an ENT doctor, a neurologist, and eventually a rheumatologist before the full picture becomes clear. The good news is that early diagnosis and modern treatments have significantly improved outcomes. With proper management, many people with EGPA can control symptoms, prevent complications, and maintain a strong quality of life.
In this guide, I’ll explain what Eosinophilic Granulomatosis with Polyangiitis is, highlight the warning signs to watch for, discuss how doctors diagnose it, and outline the treatments available today.
What Is Eosinophilic Granulomatosis with Polyangiitis?
Eosinophilic Granulomatosis with Polyangiitis (EGPA) is a rare autoimmune form of vasculitis that causes inflammation of small blood vessels.
The disease affects blood vessels that supply organs and tissues throughout the body.
Inflamed blood vessels may become:
- Narrowed
- Damaged
- Swollen
- Less effective at delivering blood flow
This inflammation can affect:
- Lungs
- Sinuses
- Skin
- Nerves
- Heart
- Kidneys
- Digestive system
Previously known as Churg-Strauss Syndrome, the medical community now refers to the condition as Eosinophilic Granulomatosis with Polyangiitis, as this name more accurately describes the disease process.
What Makes EGPA Different From Other Vasculitides?
EGPA has several features that make it unique.
Many patients have a history of:
Asthma
Asthma is one of the most common features of EGPA.
Many patients develop asthma years before other symptoms appear.
Eosinophilia
Eosinophils are white blood cells involved in allergic responses and immune activity.
In EGPA, eosinophil levels rise abnormally high and contribute to ongoing inflammation.
Vasculitis
The immune system causes inflammation of blood vessels, which can damage organs.
This combination helps doctors recognize EGPA.
What Causes Eosinophilic Granulomatosis with Polyangiitis?
The exact cause of EGPA remains unknown.
Researchers believe EGPA develops due to an abnormal immune response.
Possible contributing factors include:
Immune System Dysfunction
The immune system becomes overactive and attacks healthy tissues.
Genetic Factors
Certain genetic traits may increase susceptibility.
Environmental Triggers
Some infections, allergens, or environmental exposures may influence disease development.
Asthma and Allergy Pathways
Many researchers believe that allergic inflammation plays a key role in the development of EGPA.
However, having asthma or allergies does not necessarily mean a person will develop EGPA.
Early Symptoms of Eosinophilic Granulomatosis with Polyangiitis:
Symptoms can vary significantly between patients.
Some people develop a mild form of the disease, while others experience inflammation that affects multiple organs.
1. Asthma That Appears or Worsens in Adulthood
One of the strongest clues for EGPA is the onset of asthma later in life.
Patients may notice:
- Increased wheezing
- More frequent asthma attacks
- Greater dependence on inhalers
- Difficulty controlling symptoms
Adult-onset asthma, especially when accompanied by other inflammatory symptoms, deserves careful evaluation.
2. Chronic Sinus Problems
Many patients experience chronic inflammation of the upper airways.
Symptoms may include:
- Nasal congestion
- Sinus pressure
- Chronic sinus infections
- Nasal polyps
- Reduced sense of smell
These symptoms may appear years before diagnosis.
3. High Eosinophil Levels
A blood test may show elevated eosinophils.
High eosinophil counts can contribute to inflammation in:
- Airways
- Skin
- Nerves
- Internal organs
This finding is one of the important clues doctors use during diagnosis.
4. Fatigue
Chronic inflammation often leads to significant fatigue.
Patients often report:
- Low energy
- Weakness
- Reduced ability to complete daily activities
Fatigue can persist even when other symptoms seem mild.
5. Fever and General Illness
Some patients experience:
- Low-grade fever
- Night sweats
- Feeling generally unwell
These symptoms reflect ongoing immune system activity.
6. Skin Changes
EGPA may affect blood vessels in the skin.
Possible symptoms include:
- Purple spots
- Red patches
- Skin nodules
- Rashes
Skin symptoms may offer important diagnostic clues.
7. Numbness and Tingling
Nerve involvement is common in EGPA.
Patients may experience:
- Numbness
- Tingling
- Burning pain
- Weakness
This happens when inflammation targets the small blood vessels that supply nerves.
8. Muscle Weakness
Some patients develop weakness related to nerve or muscle inflammation.
Symptoms may include:
- Difficulty walking
- Trouble lifting objects
- Reduced strength
9. Joint Pain
Joint symptoms may include:
- Aching joints
- Stiffness
- Swelling
These symptoms can resemble those of other autoimmune diseases.
10. Shortness of Breath
Although many patients have asthma, worsening breathing symptoms may also result from inflammation in the lungs.
Warning signs include:
- Increased breathing difficulty
- Persistent cough
- Chest discomfort
11. Heart Problems
EGPA can affect the heart in some patients.
Possible complications include:
- Inflammation around the heart
- Heart muscle involvement
- Reduced heart function
Heart involvement requires ongoing monitoring and care.
12. Kidney Involvement
Kidney disease is less common in EGPA than in some other ANCA-associated vasculitides, but it can still occur.
Symptoms may include:
- Blood in urine
- Protein in urine
- Changes in kidney function
Regular monitoring can help detect kidney problems early.
How Rheumatologists Diagnose EGPA
Diagnosing EGPA requires a comprehensive look at the patient’s clinical picture.
There is no single test that can confirm the disease.
Medical History
Important questions include:
- When did asthma begin?
- Are sinus problems recurring?
- Are there nerve symptoms?
- Are eosinophil levels elevated?
- Are multiple organs involved?
The combination of symptoms often offers the most important clues.
Physical Examination
Doctors may evaluate for:
- Skin changes
- Nerve abnormalities
- Breathing problems
- Joint inflammation
Blood Tests
Common tests include:
Eosinophil Count
Measures the number of eosinophils in the blood.
ANCA Testing
Some patients have positive ANCA antibodies, although not everyone with EGPA does.
Inflammatory Markers
Tests may include:
- ESR
- CRP
These tests help measure levels of inflammation.
Imaging Studies
Depending on symptoms, testing may include:
- Chest X-rays
- CT scans
- Heart imaging
These tests help assess the extent of organ involvement.
Biopsy
A tissue biopsy may help confirm the diagnosis.
Samples may come from:
- Skin
- Lung
- Nerve
- Other affected tissues
A biopsy may reveal characteristic patterns of inflammation and granuloma formation.
Treatment Options for Eosinophilic Granulomatosis with Polyangiitis:
Treatment depends on:
- Severity of disease
- Organs that are involved
- Risk of complications
The main goals of treatment are to:
- Control inflammation
- Reduce eosinophil activity
- Protect organs
- Achieve remission
Corticosteroids
Steroids are commonly used to quickly control inflammation.
Many patients notice significant improvement after starting treatment.
Immunosuppressive Medications
Depending on severity, treatment may include:
- Methotrexate
- Azathioprine
- Cyclophosphamide
- Mycophenolate mofetil
These medications help suppress abnormal immune activity.
Biologic Therapy
Targeted therapies have become increasingly important in the treatment of EGPA.
Medications that target eosinophil-driven inflammation may help control disease activity and reduce the need for steroids.
Asthma Management
Because asthma is central to EGPA, treatment may include:
- Inhaled medications
- Allergy management
- Pulmonary follow-up
Living With Eosinophilic Granulomatosis with Polyangiitis:
A diagnosis of EGPA can feel overwhelming, as the disease often affects multiple body systems.
However, advances in treatment have significantly improved patient outcomes.
Many patients can:
- Control asthma symptoms
- Prevent organ damage
- Continue normal activities
- Maintain an active and fulfilling lifestyle
Long-term care typically involves regular check-ups with a rheumatologist and other specialists.
When Should You See a Rheumatologist?
Seek evaluation if you experience:
- Adult-onset asthma
- Persistent sinus problems
- High eosinophil levels
- Numbness or tingling
- Unexplained rash
- Shortness of breath
- Fatigue with inflammatory symptoms
- Multiple symptoms affecting different organs
Early recognition and intervention can help prevent serious complications.
Frequently Asked Questions
Is Eosinophilic Granulomatosis with Polyangiitis an autoimmune disease?
Yes. EGPA is an autoimmune vasculitis in which the immune system attacks blood vessels, causing inflammation.
Is Churg-Strauss Syndrome the same as EGPA?
Yes. Churg-Strauss Syndrome is the former name for Eosinophilic Granulomatosis with Polyangiitis.
Can EGPA be cured?
There is currently no cure, but many patients can achieve remission with treatment.
Does everyone with EGPA have ANCA antibodies?
No. Some patients test positive for ANCA antibodies, while others do not.
What specialist treats EGPA?
A rheumatologist usually coordinates care and often works closely with pulmonologists, allergists, neurologists, and other specialists.
A Rheumatologist’s Perspective on Eosinophilic Granulomatosis with Polyangiitis
One of the biggest challenges with EGPA is recognizing that symptoms affecting different parts of the body may actually be linked.
Asthma, sinus problems, nerve symptoms, skin changes, and fatigue may seem like separate issues. However, when these symptoms occur together—especially alongside elevated eosinophils—a thorough evaluation is essential.
The most important message I share with patients is that EGPA is a serious condition, but it’s also highly treatable when diagnosed early.
Modern therapies allow many people with Eosinophilic Granulomatosis with Polyangiitis to achieve disease control, protect their organs, and continue leading healthy, active lives. Schedule Your Appointment with us at the Arthritis Medical Clinic.